#5 of our Top 10 Altmetric Papers of 2024 Countdown!
5️⃣ Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
🛑 Everything you need to know about DOAC reversal.
📅 Published: 17 Jul 2024
🔗 www.jthjournal.org/article/S153...
#JTHCountDown2024
#JTHCountDown2024
#6 of our Top 10 Altmetric Papers of 2024 Countdown!
6️⃣ Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH
🔗 www.jthjournal.org/article/S153...
#JTHCountDown2024
#7 of our Top 10 Altmetric Papers of 2024 Countdown!
7️⃣ Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
📊 Important insights into therapy duration!
📅 Published: 16 May 2024
🔗 www.jthjournal.org/article/S153...
#JTHCountDown2024
#8 of our Top 10 Altmetric Papers of 2024 Countdown!
8️⃣ Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A
🧬 The long-term potential of gene therapy in hemophilia.
📅 Published: 12 Apr 2024
🔗 www.jthjournal.org/article/S153...
#JTHCountDown2024
#9 of our Top 10 Altmetric Papers of 2024 Countdown! 🏆
9️⃣ Disparities in access to and timing of interventional therapies for pulmonary embolism across the United States
📅 Published: 28 Mar 2024
🌍 A deep dive into healthcare inequities.
#JTHCountDown2024
🔗 www.jthjournal.org/article/S153...